Innoviva (INVA) Dividends Paid - Common Growth (1y) (2015 - 2022)
Innoviva (INVA) Dividends Paid - Common Growth (1y) (2015 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Div. Paid (Common) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Innoviva |
1.66 Bn |
1.05 Bn |
75.83 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
50.59% |
| Jun 30, 2022 |
-52.65% |
| Mar 31, 2022 |
-69.43% |
| Jun 30, 2021 |
65.91% |
| Mar 31, 2021 |
34.63% |
| Dec 31, 2020 |
-76.17% |
| Jun 30, 2020 |
404,966.67% |
| Mar 31, 2020 |
197,525.00% |
| Dec 31, 2019 |
243.72% |
| Jun 30, 2019 |
-99.65% |
| Mar 31, 2019 |
-78.95% |
| Dec 31, 2018 |
991.46% |
| Sep 30, 2018 |
1,958.88% |
| Jun 30, 2018 |
2,052.50% |
| Mar 31, 2018 |
-43.28% |
| Dec 31, 2017 |
332.31% |
| Sep 30, 2017 |
-305.77% |
| Jun 30, 2017 |
-67.74% |
| Mar 31, 2017 |
-90.68% |
| Dec 31, 2016 |
-65.24% |
